IL-32γ induces chemotaxis of activated T cells via dendritic cell-derived CCL5

Mi Hye Son, Mi Young Jung, Seulah Choi, Dae Ho Cho, Tae Sung Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Interleukin (IL)-32 has been associated with a variety of inflammatory diseases including rheumatoid arthritis, vasculitis and Crohn's disease. We have previously reported that IL-32γ, the IL-32 isoform with the highest biological activity, could act as an immune modulator through regulation of dendritic cell (DC) functions in immune responses. Cell locomotion is crucial for induction of an effective immune response. In this study, we investigated the effect and underlying mechanisms of IL-32γ on recruitment of T cells. IL-32γ upregulated the expression of several chemokines including CCL2, CCL4, and CCL5 in the DCs. In particular, IL-32γ significantly increased CCL5 expression in a dose-dependent manner. Treatment with JNK and NF-κB inhibitors suppressed IL-32γ-induced CCL5 expression in DCs, indicating that IL-32γ induced CCL5 production through the JNK and NF-κB pathways. Furthermore, supernatants from IL-32γ-treated DCs showed chemotactic activities controlling migration of activated CD4+ and CD8+ T cells, and these activities were suppressed by addition of neutralizing anti-CCL5 antibody. These results show that IL-32γ effectively promotes migration of activated T cells via CCL5 production in DCs. The chemotactic potential of IL-32γ may explain the pro-inflammatory effects of IL-32 and the pathologic role of IL-32 in immune disorders such as rheumatoid arthritis.

Original languageEnglish
Pages (from-to)30-35
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume450
Issue number1
DOIs
Publication statusPublished - 2014 Jul 18

Fingerprint

T-cells
Interleukins
Chemotaxis
Dendritic Cells
T-Lymphocytes
Rheumatoid Arthritis
Rheumatoid Vasculitis
Chemokine CCL2
Immune System Diseases
Bioactivity
Neutralizing Antibodies
Chemokines
Crohn Disease
Modulators
Cell Movement
Anti-Idiotypic Antibodies
Protein Isoforms

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

IL-32γ induces chemotaxis of activated T cells via dendritic cell-derived CCL5. / Son, Mi Hye; Jung, Mi Young; Choi, Seulah; Cho, Dae Ho; Kim, Tae Sung.

In: Biochemical and Biophysical Research Communications, Vol. 450, No. 1, 18.07.2014, p. 30-35.

Research output: Contribution to journalArticle

@article{cd8aa90614e64e13ac6783d04ef1c6fe,
title = "IL-32γ induces chemotaxis of activated T cells via dendritic cell-derived CCL5",
abstract = "Interleukin (IL)-32 has been associated with a variety of inflammatory diseases including rheumatoid arthritis, vasculitis and Crohn's disease. We have previously reported that IL-32γ, the IL-32 isoform with the highest biological activity, could act as an immune modulator through regulation of dendritic cell (DC) functions in immune responses. Cell locomotion is crucial for induction of an effective immune response. In this study, we investigated the effect and underlying mechanisms of IL-32γ on recruitment of T cells. IL-32γ upregulated the expression of several chemokines including CCL2, CCL4, and CCL5 in the DCs. In particular, IL-32γ significantly increased CCL5 expression in a dose-dependent manner. Treatment with JNK and NF-κB inhibitors suppressed IL-32γ-induced CCL5 expression in DCs, indicating that IL-32γ induced CCL5 production through the JNK and NF-κB pathways. Furthermore, supernatants from IL-32γ-treated DCs showed chemotactic activities controlling migration of activated CD4+ and CD8+ T cells, and these activities were suppressed by addition of neutralizing anti-CCL5 antibody. These results show that IL-32γ effectively promotes migration of activated T cells via CCL5 production in DCs. The chemotactic potential of IL-32γ may explain the pro-inflammatory effects of IL-32 and the pathologic role of IL-32 in immune disorders such as rheumatoid arthritis.",
keywords = "Activated T cells, CCL5, Chemotaxis, Dendritic cells, IL-32",
author = "Son, {Mi Hye} and Jung, {Mi Young} and Seulah Choi and Cho, {Dae Ho} and Kim, {Tae Sung}",
year = "2014",
month = "7",
day = "18",
doi = "10.1016/j.bbrc.2014.05.052",
language = "English",
volume = "450",
pages = "30--35",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - IL-32γ induces chemotaxis of activated T cells via dendritic cell-derived CCL5

AU - Son, Mi Hye

AU - Jung, Mi Young

AU - Choi, Seulah

AU - Cho, Dae Ho

AU - Kim, Tae Sung

PY - 2014/7/18

Y1 - 2014/7/18

N2 - Interleukin (IL)-32 has been associated with a variety of inflammatory diseases including rheumatoid arthritis, vasculitis and Crohn's disease. We have previously reported that IL-32γ, the IL-32 isoform with the highest biological activity, could act as an immune modulator through regulation of dendritic cell (DC) functions in immune responses. Cell locomotion is crucial for induction of an effective immune response. In this study, we investigated the effect and underlying mechanisms of IL-32γ on recruitment of T cells. IL-32γ upregulated the expression of several chemokines including CCL2, CCL4, and CCL5 in the DCs. In particular, IL-32γ significantly increased CCL5 expression in a dose-dependent manner. Treatment with JNK and NF-κB inhibitors suppressed IL-32γ-induced CCL5 expression in DCs, indicating that IL-32γ induced CCL5 production through the JNK and NF-κB pathways. Furthermore, supernatants from IL-32γ-treated DCs showed chemotactic activities controlling migration of activated CD4+ and CD8+ T cells, and these activities were suppressed by addition of neutralizing anti-CCL5 antibody. These results show that IL-32γ effectively promotes migration of activated T cells via CCL5 production in DCs. The chemotactic potential of IL-32γ may explain the pro-inflammatory effects of IL-32 and the pathologic role of IL-32 in immune disorders such as rheumatoid arthritis.

AB - Interleukin (IL)-32 has been associated with a variety of inflammatory diseases including rheumatoid arthritis, vasculitis and Crohn's disease. We have previously reported that IL-32γ, the IL-32 isoform with the highest biological activity, could act as an immune modulator through regulation of dendritic cell (DC) functions in immune responses. Cell locomotion is crucial for induction of an effective immune response. In this study, we investigated the effect and underlying mechanisms of IL-32γ on recruitment of T cells. IL-32γ upregulated the expression of several chemokines including CCL2, CCL4, and CCL5 in the DCs. In particular, IL-32γ significantly increased CCL5 expression in a dose-dependent manner. Treatment with JNK and NF-κB inhibitors suppressed IL-32γ-induced CCL5 expression in DCs, indicating that IL-32γ induced CCL5 production through the JNK and NF-κB pathways. Furthermore, supernatants from IL-32γ-treated DCs showed chemotactic activities controlling migration of activated CD4+ and CD8+ T cells, and these activities were suppressed by addition of neutralizing anti-CCL5 antibody. These results show that IL-32γ effectively promotes migration of activated T cells via CCL5 production in DCs. The chemotactic potential of IL-32γ may explain the pro-inflammatory effects of IL-32 and the pathologic role of IL-32 in immune disorders such as rheumatoid arthritis.

KW - Activated T cells

KW - CCL5

KW - Chemotaxis

KW - Dendritic cells

KW - IL-32

UR - http://www.scopus.com/inward/record.url?scp=84904724942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904724942&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2014.05.052

DO - 10.1016/j.bbrc.2014.05.052

M3 - Article

VL - 450

SP - 30

EP - 35

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 1

ER -